Understanding schizophrenia and diabetes

Hospital Medicine

Volumn 65, Issue 8, 2004, Pages 485-488

  Dinan, Ted ^a,d   Peveler, Robert ^b   Holt, Richard ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Liaison Psychiatry ^*

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NEUROLEPTIC AGENT;

ANAMNESIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIABETES MELLITUS; DIAGNOSTIC TEST; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HEALTH CARE; HEALTH CARE ACCESS; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MEDICAL SPECIALIST; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POPULATION; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCREENING; SYMPTOM;

EID: 4444251446     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2004.65.8.15495     Document Type: Review

References (19)

1. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27(suppl 1): S5-S10
2. Braceland FJ, Meduna LJ, Vaichulis JA (1945) Delayed action of insulin in schizophrenia. Am J Psychiatry 102: 108-10
3. Brown S, Birtwistle J, Roe L et al (1999) The unhealthy lifestyle of people with schizophrenia. Psychol Med 29: 697-701
4. Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry 177: 212-17
5. Cohn T, Wolever T, Zipursky R et al (2002) Screening for diabetes and impaired glucose tolerance in patients on antipsychotic medication. Int J Neuropsvchopharmacol 5 (Suppl 1): S168
6. Department of Health (2001) National Service Framework for Diabetes. Guidance. Department of Health, London
7. Department of Health (2003) National Service Framework for Diabetes. Service Delivery. Department of Health, London
8. Dinan TG, Holt RIG, Kohen D et al (2004) Schizophrenia and diabetes 2003: an expert consensus meeting. Br J Psychiatry 184(suppl 47): 112
9. Dixon L, Weiden P, Delananty J et al (2000) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophren Bull 26: 903-12
10. Freeman H (1946) Resistance to insulin in mentally disturbed soldiers. AMA Arch Neurol Psychiatry 56: 74-8
11. Freeman H, Rodnick EH, Shakow D et al (1944) The carbohydrate tolerance of mentally disturbed soldiers. Psychosom Med 6: 311-17
12. Haddad PM (2004) Antipsychotics and diabetes: review of non-prospective data. Schizophrenia and diabetes 2003: an expert consensus meeting. Br J Psychiatry 184(suppl 47): 80
13. Henry GW, Mangan E (1925) Blood in personality disorders: biochemical studies. AMA Arch Neurol Psychiatry 13: 743-9
14. Jin H, Meyer JM, Jeste DV (2002) Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases. Ann Clin Psychiatry 14: 59-64
15. Kooy FH (1919) Hyperglycemia in mental disorders. Brain 42: 214-88
16. Lorenz WF (1922) Sugar tolerance in dementia praecox and other mental disorders. AMA Arch Neurol Psychiatry 8: 184-96
17. Maudsley H (1979) The Pathology of Mind. 3rd edn. Macmillan, London
18. Ryan MCM, Collins P, Thakore JH (2003) Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. Am J Psychiatry 160: 284-9
19. Subramaniam M, Chong S-A, Pek E (2003) Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry 48: 345-7